Trials / NCT05534347
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
Recruiting now Observational Natural history / observational
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Treatment
- Blood sample; Joint puncture
- Gene
- Not stated
- Conditions
- Juvenile Idiopathic Arthritis (JIA)
- Ages
- 16 Years to no upper limit
- Enrollment
- 300 participants
- Started
- 2023-03-13
- Main results expected
- 2030-03
- Results posted
- Not yet
- Record last updated
- 2025-09-12
What the study is testing
The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and/or therapeutic escalation.
Where it runs
France (1)
- Rheumatology Department, Cochin Hospital, Paris, IDF (recruiting now)